All Articles

Starlight Investments' 'The Lively' delivers new rental units in a tight market, prioritizing senior housing and showcasing successful infill development in North Vancouver. The project reflects a broader trend in Canada’s rental landscape.

Express Wash Concepts' EWC Cares initiative awarded $280,000 in grants, fueled by a 64% increase in fundraising. How the chain is redefining corporate social responsibility and boosting local economies.

A leading materials science company unveils a potential breakthrough in tire technology, offering an alternative to a chemical linked to the deaths of coho salmon and other aquatic life. The innovation faces regulatory hurdles and competition.

A new initiative from Good Earth Coffeehouse and GenWell aims to combat rising loneliness by encouraging Canadians to simply talk to strangers. Is a little human connection the key to better well-being?

Endpoint management firm Tanium is doubling down on artificial intelligence and expanding into operational technology and mobile, aiming to deliver a truly autonomous IT experience. But can its vision overcome a crowded market?

Galloway Capital Partners takes a 3.15% stake in PodcastOne, urging a sale or merger. Can the podcasting platform unlock value amid industry consolidation and a shifting audio landscape?

Homewerks Worldwide’s acquisition of Character Project Kits signals a growing trend towards empowering homeowners with accessible DIY plumbing solutions. The deal positions the company to capitalize on a booming home improvement market.

With the Artemis II mission slated for early 2026, Canada is poised to achieve a landmark moment in space exploration. Astronaut Jeremy Hansen will become the first Canadian to journey around the Moon, marking a significant investment in international collaboration and a bold step forward for the Canadian space program.

New survey reveals growing pressure on marketers to localize content faster and more effectively, fueling demand for AI-powered translation solutions. But can AI truly deliver brand consistency and accuracy?

A massive data breach affecting millions of Canadian students highlights critical weaknesses in how schools protect sensitive information when using third-party edtech providers. Experts warn the incident is just the tip of the iceberg.

Acquisition aims to bridge the gap between vulnerability identification & business impact with an AI-driven platform. A push towards autonomous cybersecurity.

A new blood-based test from PrognomiQ aims to revolutionize lung cancer screening. While early data is promising, experts caution that accessibility and wider validation are crucial.

Creative workflow specialist launches 'Santa Cruz Software Labs,' aiming to establish a new standard for responsible AI in marketing and creative technology, addressing growing concerns around bias, transparency, and authorship.

Family office innovator Mondevo Group acquires AI firm Meight, rebranding it as MonTech, in a move signaling a shift towards fully integrated, in-house AI capabilities. The move aims to create a 'technology moat' and accelerate innovation.

Ontario Securities Commission case management hearing set for Nayeem Alli, stemming from allegations of violating a previous order prohibiting him from serving as a director or officer. A history of investor harm revealed.

As downtime costs soar, Fusion Risk Management introduces a new feature automating disaster recovery sequencing. Can this tech shift resilience from reactive response to proactive prevention?

BizClik Media’s Procurement Magazine is shifting to a bi-weekly publishing schedule, signaling confidence in the growing procurement technology market and a commitment to delivering timely content for industry leaders.

First Pacific Advisors’ 10% investment in Azelis comes as the specialty chemical distributor navigates a challenging market. Analysts dissect the move, examining both strategic potential and underlying concerns.

New data reveals a boom in Canada's exempt market, as companies increasingly bypass traditional funding routes. Investors must weigh the opportunities against heightened risks in this rapidly evolving landscape.

FDA approval of Arrowhead Pharmaceuticals’ REDEMPLO for familial chylomicronemia syndrome marks a scientific breakthrough and a bold pricing strategy poised to reshape the market for ultra-rare disease therapies.